Axatilimab Immunogenicity and Clinical Relevance in Patients with Chronic Graft‐Versus‐Host Disease
Axatilimab, a monoclonal antibody targeting colony‐stimulating factor 1 (CSF‐1) receptor, is approved in the US for the treatment of chronic graft‐versus‐host disease (cGVHD) after failure of ≥2 lines of systemic therapy. In this study, the effects of antidrug antibody (ADA) status on the pharmacokinetics, pharmacodynamics, efficacy, and safety of ...
Yan‐ou Yang +4 more
wiley +1 more source
Impact of excessive environmental information disclosure on stock price crash risk. [PDF]
Dong G, Ma G.
europepmc +1 more source
Baloxavir acid (baloxavir), the active metabolite of the prodrug baloxavir marboxil, is a selective inhibitor of the influenza virus cap‐dependent endonuclease. The population pharmacokinetic (popPK) profile of baloxavir in adults/adolescents has been described previously.
Sylvie Retout +6 more
wiley +1 more source
Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial. [PDF]
Rasouli N +9 more
europepmc +1 more source
Balancing evidence and individualization in adjuvant CDK4/6 therapy. [PDF]
Al-Shamsi HO, Oner M, Mokbel K.
europepmc +1 more source
From union clout to corporate couture: Unveiling the impact of trade unions on corporate social responsibility. [PDF]
Mandliya A +3 more
europepmc +1 more source
Context matters: evaluating AI-assisted chest radiograph interpretation in military field hospitals. [PDF]
Callcut RA.
europepmc +1 more source
Controlling shareholders' share pledge and share repurchase notices of listed companies. [PDF]
Cao L, Zhu X, Xie J.
europepmc +1 more source
Quantum speedup for nonreversible Markov chains. [PDF]
Claudon B, Piquemal JP, Monmarché P.
europepmc +1 more source

